If you spend any time on social media, you’ve probably seen the stories. Someone shares a dramatic before-and-after photo. Another person talks about finally feeling in control of their appetite. Others post videos about difficult side effects or what happened after they stopped treatment. GLP-1 medications have become one of the most talked-about health topics […]
Recent media reports have raised understandable concerns about the safety of GLP-1 medicines such as Mounjaro (tirzepatide) and Wegovy/Ozempic (semaglutide), with headlines suggesting that hundreds of deaths have been linked to these treatments. The figures can sound alarming. However, it is important to understand what these reports actually mean – and what they do not […]
You may have come across the term ‘microdosing‘ on social media or in online support groups. Microdosing refers to taking smaller doses of a GLP-1 medicine (such as Mounjaro® or Wegovy®) than those recommended in the licensed prescribing schedule, increasing the dose more slowly than usual, or taking the medication less frequently than prescribed. Some people choose […]
One of the most important studies examining this question is the DIETFITS trial, a large, well-designed clinical trial published in JAMA in 2018. What the science says about healthy weight loss The study included 609 adults aged 18–50 years with overweight or obesity (BMI 28–40 kg/m²), of whom 57% were women. Participants were randomly assigned […]